NEW YORK (GenomeWeb News) – Eurofins MWG Operon of Germany and Floragenex of Portland, Ore., will co-market their services for Restriction Site Associated DNA sequencing, or RAD-seq, the companies said today.

Under the agreement, the companies will jointly market their respective expertise in next-generation sequencing and genomic services around RAD-seq, which is used for SNP marker discovery and genotyping, particularly in genetically complex or little-characterized organisms.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.